Eylea’s Role in Retinal Vein Occlusion Care
Eylea (Aflibercept) stands as a pivotal treatment for retinal vein occlusion (RVO), specifically targeting central retinal vein occlusion (CRVO) by combating macular edema through anti-VEGF action. The upcoming sections delve into its treatment process, potential side effects, efficacy, safety considerations, and the importance of regular monitoring, offering a well-rounded understanding of Eylea’s role in vision […]
3 minute read